We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ANIX market cap is 98.79M. The company's latest EPS is USD -0.3049 and P/E is -10.10.
| Quarter End | Jul 2023 | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.84M | -3.05M | -3.61M | -3.47M | -3.59M |
| Net Income | -2.51M | -2.69M | -3.26M | -3.14M | -3.28M |
| Year End 31 October 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 250k | 0 | 513k | 0 | 210k |
| Operating Income | -11.89M | -9.98M | -13.14M | -13.88M | -11.01M |
| Net Income | -11.65M | -10.02M | -12.95M | -13.6M | -9.81M |
| Quarter End | Jul 2023 | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 26.58M | 25.52M | 25.37M | 24.36M | 22.91M |
| Total Liabilities | 1.99M | 2.15M | 1.77M | 1.77M | 2.22M |
| Total Equity | 24.59M | 23.37M | 23.6M | 22.58M | 20.69M |
| Year End 31 October 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.29M | 9.45M | 36.26M | 30.41M | 25.52M |
| Total Liabilities | 1.48M | 1.19M | 1.49M | 2.21M | 2.15M |
| Total Equity | 4.81M | 8.26M | 34.77M | 28.2M | 23.37M |
| Quarter End | Jul 2023 | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.24M | -6.21M | -2.31M | -3.77M | -6.41M |
| Investing | -5.01M | -5.6M | 129k | 685k | 3.41M |
| Financing | 87k | 366k | 2.26M | 3.16M | 3.31M |
| Year End 31 October 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.74M | -6.18M | -4.94M | -6.49M | -6.21M |
| Investing | -525k | -306k | -3.92M | -10.73M | -5.6M |
| Financing | 5.7M | 9.41M | 31.57M | 452k | 366k |
| Market Cap | 98.79M |
| Price to Earnings Ratio | -10.10 |
| Price to Sales Ratio | 473.85 |
| Price to Cash Ratio | 108.45 |
| Price to Book Ratio | 4.24 |
| Dividend Yield | - |
| Shares Outstanding | 32.18M |
| Average Volume (1 week) | 72.47k |
| Average Volume (1 Month) | 126.46k |
| 52 Week Change | 4.07% |
| 52 Week High | 5.13 |
| 52 Week Low | 2.16 |
| Spread (Intraday) | 0.02 (0.65%) |
| Company Name | Anixa Biosciences Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.anixa.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
